Business Context and Reporting Period
Company: Healthcare Trust of America, Inc. (NYSE: HTA) and its operating partnership, Healthcare Trust of America Holdings, LP.
Filing Type: Form 8-K (Current Report)
Date of Report: September 16, 2019
Event: Entry into a Material Definitive Agreement regarding a public offering of senior notes.
Key Financial Metrics and Capital Structure
This filing details a debt issuance rather than operational financial results. Key metrics regarding the new capital structure include:
- Total Offering Size: $900.0 million aggregate principal amount.
- 2026 Notes: $250.0 million principal; 3.500% coupon; issued at 103.660% of principal; matures August 1, 2026.
- 2030 Notes: $650.0 million principal; 3.100% coupon; issued at 99.658% of principal; matures February 15, 2030.
- Accrued Interest: $1,093,750.00 accrued on 2026 Notes from August 1, 2019.
- Debt Ranking: General unsecured and unsubordinated obligations, ranking equally with existing senior unsecured debt (2021, 2022, 2023, 2026, and 2027 Notes) and senior to subordinated indebtedness.
- Guarantees: Fully and unconditionally guaranteed by Healthcare Trust of America, Inc. (HTA), subject to automatic release conditions for the 2030 Notes.
Note: The filing text does not provide values for revenue, net income, operating cash flow, or liquidity ratios.
Material Changes and Covenants
The primary material change is the expansion of the company's senior unsecured debt portfolio by $900.0 million. The indentures contain restrictive covenants, including:
- Limitations on the ability to incur additional indebtedness.
- Requirements to maintain a pool of unencumbered assets.
- Requirements to maintain insurance with financially sound companies.
- Events of Default: Include failure to pay interest for 90 days, failure to pay principal, failure to cure other defaults within 90 days, and cross-default provisions for indebtedness exceeding $35.0 million (2026 Notes) or $50.0 million (2030 Notes).
Guidance, Outlook, and Redemption Terms
The filing does not contain forward-looking guidance, management commentary on operational outlook, or discussion of risks beyond standard indenture defaults. However, it outlines specific redemption terms:
- 2026 Notes: Redeemable prior to May 1, 2026, at a price equal to the greater of 100% of principal or the present value of remaining payments plus 0.35%. After May 1, 2026, redeemable at 100% of principal.
- 2030 Notes: Redeemable prior to November 15, 2029, at a price equal to the greater of 100% of principal or the present value of remaining payments plus 0.25%. After November 15, 2029, redeemable at 100% of principal.
Investor Verification Checklist
- Verify the total net proceeds received after deducting underwriting discounts and commissions (not explicitly stated in this text).
- Confirm the specific use of proceeds for the $900.0 million offering (not explicitly stated in this text).
- Review the full text of the Indentures (Exhibits 4.1 and 4.2) for detailed covenant calculations and definitions of "Significant Subsidiaries."
- Assess the impact of the new debt on the company's leverage ratios and interest coverage, as these metrics are not provided in the 8-K.
- Monitor the status of the guarantee release conditions for the 2030 Notes relative to the retirement of other senior notes.